Keros Therapeutics Alternatives & Competitors
12 companies similar to Keros Therapeutics — Keros is dedicated to the discovery and development of novel therapeutics for mu...
Companies similar to Keros Therapeutics
Geron Corporation
Changing lives by changing the course of blood cancer.
OrsoBio
Advancing first-in-class therapies to restore energy homeostasis
Palo Alto, United States
Oncotelic
AI driven developer of immunotherapeutics against cancer and covid-19 and other viruses
Agoura Hills, United Stat...
MORPHOGEN-IX LIMITED
"Advancing novel therapies for pulmonary arterial hypertension through pioneering research...
Rival Readout
Competing with Keros Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Lumos Pharma
Transforming Lives with Rare Focus
Austin, United States
Endeavor BioMedicines
Boldly pursuing development of transformational medicines that may restore hope for patien...
San Diego, United States
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
AMO Pharma LTD
AMO Pharma is working to develop novel therapeutics for rare genetic neurodevelopmental di...
Durham, United States
Neumora
Pioneering a new era of medicines for brain diseases
Watertown, United States
Nuvamid
A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...
Nyon, Switzerland
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Cambridge, United States
About Keros Therapeutics
Keros Therapeutics, founded in 2016, is a biotechnology innovator headquartered in the United States and operates across several key industries, including Biotechnology, Health Care, Health and Wellness, and Pharmaceutical. The company is dedicated to the discovery and development of novel therapeutics aimed at treatin...
Development of novel therapeutics, Modulation of TGF-beta signaling, Clinical trials for drug candidates, Hematology and neuromuscular franchises
Patients with TGF-beta related disorders, Healthcare professionals, Research institutions, Neuromuscular disorder specialists
Biopharmaceutical, Therapeutics Development, TGF-ß Signaling, Hematologic Disorders, Musculoskeletal Disorders, Clinical-stage Company, Cytopenias Treatment, Myelodysplastic Syndromes, Myelofibrosis, Anemia Treatment, Thrombocytopenia, Hepcidin Regulation, Fibrodysplasia Ossificans Progressiva, Osteoporosis Treatment, Pulmonary Arterial Hypertension
B2B, B2C, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Keros Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Keros Therapeutics on 18 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
